Developing Digital Twin Modelling for Lung Cancer Management Powered by Deep Learning-based Survival Analysis, Risk Stratification and Decision Support Recommendations

Median Technologies And Olea Medical, A Canon Medical Systems Company, Partner To Advance Commercial Deployment Of AI-Powered Eyonis® LCS For Lung Cancer Screening

Under the terms of the agreement, Olea Medical and Median Technologies will support the commercialization of eyonis® LCS across the United States and Europe, as well as in other geographies that may be mutually agreed upon over time The post Median Technologies and Olea Medical, a Canon Medical Systems Company, Partner to Advance Commercial Deployment of AI-Powered eyonis® LCS for Lung Cancer Screening first appeared on Medical Device News Magaz…

Developing Digital Twin Modelling for Lung Cancer Management Powered by Deep Learning-based Survival Analysis, Risk Stratification and Decision Support Recommendations

Hybridization of artificial intelligence with Digital Twin (DT) modellinghas shown a great transformative potential in the healthcare sector, especially in diagnosing and managing thoracic diseases. Lung cancer remains one of the most common and deadly forms of cancer, emphasizing the critical...